Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Perhaps the most critical aspect of Moderna's business to pay attention to right now is its late-stage pipeline. The company ...

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

While Moderna is certainly enthusiastic about its near-term mRNA prospects, the company’s COVID-19 business is going through an odd patch, which has afflicted pandemic players of all stripes.

Neither UTMB nor Moderna has confirmed the nature of the project included in the announcement, or how much funding is being ...

If Canada is serious about becoming a global powerhouse in fields such as AI and life sciences then this intrapreneur mindset ...

Moderna plans to submit the latest data from the teens to the U.S. Food and Drug Administration to expand the current authorization for its vaccine to children as young as 12 years old.

Stefan Raos is the general manager at Moderna Canada. Leslie Madden is the head of government affairs and policy at Moderna Canada. We all carry our experiences into the workplace. They shape how we ...

Moderna CEO and billionaire Stéphane Bancel recently told The Wall Street Journal that Moderna may quadruple the price of their Covid-19 mRNA vaccines. (Photo by JOEL SAGET/AFP via Getty Images) ...